Trade Show News
Stay updated with the latest trade show news through detailed press releases. Learn about upcoming events, key highlights, and industry trends. Get insights into significant trade show announcements, exhibitor information, and post-event analyses.
May 30, 2026 at 2:30 PM
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
GAITHERSBURG, Md.--(BUSINESS WIRE)--Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced updated data from the Phase 1/2 study of JK06, a 5T4-targeted antibody drug conjugate (ADC), in patients with unresectable locally advanced or metastatic solid tumors, including non-small cell lung cancer (NSCLC) and breast cancer. The data are being presented at the 2026 American Soc...
May 30, 2026 at 8:00 AM
Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026
DURHAM, N.C. & SEATTLE--(BUSINESS WIRE)--Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of Liver (EASL) Congress in Barcelona, Spain, demonstrating the first clinical evidence of epigenetic silencing in hepatitis B virus (HBV). The oral presentation was delivered by Dr. Ed Gane, Professor of Medicine at the University of Auckland and world-renowned authority on HBV. The phase 1b/2a clinical trial evaluated the safety an...
May 30, 2026 at 8:00 AM
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
NEW YORK--(BUSINESS WIRE)--TALAPRO-3 Data Presented at ASCO...
May 29, 2026 at 11:30 AM
Virion Therapeutics Reports Progress Towards HBV Functional Cure with Continued HBsAg Declines, Without Rebound, Up to Two Plus Years, After a Single VRON-0200 Dose, From its Phase 1b Study at EASL 2026
PHILADELPHIA--(BUSINESS WIRE)--Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the EASL Congress 2026 (The European Association for the Study of the Liver) in Barcelona, Spain, that a single intramuscular dose of VRON-0200, its novel, first-in-class, immunotherapy for HBV Functional Cure, induced HBV-specific immune activation, restoration, and continued HBsAg declines, without...
May 29, 2026 at 10:50 AM
FlexGen and CES Strengthen End-to-End Support for Battery Storage, Hybrid Projects
DURHAM, N.C.--(BUSINESS WIRE)--As FlexGen integrates CES to its portfolio, customers will benefit from a larger domestic servicing team across battery storage and solar projects....
May 29, 2026 at 10:19 AM
AM Best to Speak, Sponsor and Exhibit at the Philippine Insurance Summit
SINGAPORE--(BUSINESS WIRE)--AM Best will speak, sponsor and exhibit at the Philippine Insurance Summit on Wednesday, 3 June 2026 in Makati City, Philippines at the Fairmont Hotel. Johnathan Wong, senior market development analyst, AM Best, will discuss AM Best’s latest outlook on the Philippine non-life insurance segment at 11:40 AM. Additionally, Rob Curtis, managing director and chief executive officer of AM Best’s Singapore operations will also be in attendance for meetings. To arrange a mee...
May 29, 2026 at 9:00 AM
Newegg Returns to COMPUTEX 2026 with Largest Gamer Zone Yet, Live PC Builder Mod Simulator Showdown, and Debut of Newegg Simulator Builder
DIAMOND BAR, Calif.--(BUSINESS WIRE)--Newegg (Newegg Commerce, Inc., NASDAQ: NEGG), a global leader in computer and technology products, today announced its participation at the 2026 Taipei International Computer Show (COMPUTEX 2026), taking place June 2–5. Marking Newegg's 25th anniversary year, the showcase is the company's largest-ever Computex footprint, anchored by an expanded Gamer Zone, the debut of Newegg Simulator Builder, and an international PC Builder Championship featuring leading...
May 29, 2026 at 9:00 AM
Accelerant to Present at William Blair’s 46th Annual Growth Stock Conference
ATLANTA--(BUSINESS WIRE)--Accelerant (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced Jeff Radke, Chairman and Chief Executive Officer, will be presenting at the William Blair Growth Stock Conference on Wednesday, June 3, 2026 at 10:20 am Eastern Time. A live webcast of the presentation can be accessed from the investor relations section on the Company's website at www.investor.accelerant.a...
May 29, 2026 at 8:05 AM
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will participate in the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting, taking place May 29 – June 2, 2026 in Cleveland, Ohio. At the meeting, NeuroPace will highlight the expanding role of responsive neuromodulation in epilepsy care, including long-term clinical out...
May 29, 2026 at 8:00 AM
Okta to Present at Upcoming Investor Conferences
SAN FRANCISCO--(BUSINESS WIRE)--Okta, Inc. (Nasdaq: OKTA), the leading independent identity provider, today announced that a member of its management team is scheduled to participate in an upcoming investor conference. Details for the event are as follows: Evercore TMT Conference Wednesday, June 3, 2026 1:20 p.m. Pacific time (4:20 p.m. Eastern time) FBN Virtual Technology Conference Wednesday, June 10, 2026 11:30 a.m. Pacific time (2:30 p.m. Eastern time) The presentations will be webcast live...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.